Condensed Statements of Changes in Stockholders' Equity - USD ($)		Common Stock	Additional Paid-In Capital	Accumulated Deficit	Total
Balance at the beginning at Dec. 31, 2021		$ 2,844	$ 110,683,077	$ (90,219,306)	$ 20,466,615
Balance at the beginning (in shares) at Dec. 31, 2021		28,426,616
Stock-based compensation			908,987		908,987
Issuance of common stock related to vested restricted stock units		$ 2	(2)
Issuance of common stock related to vested restricted stock units (in shares)		19,359
Issuance of common stock and warrants in registered direct offering	[1]	$ 300	14,897,608		14,897,908
Issuance of common stock and warrants in registered direct offering (in shares)	[1]	3,000,000
Issuance of common stock in At the Market offering	[2]	$ 25	860,340		860,365
Issuance of common stock in At the Market offering (in shares)	[2]	252,449
Net loss				(7,339,665)	(7,339,665)
Balance at the end at Mar. 31, 2022		$ 3,171	127,350,010	(97,558,971)	29,794,210
Balance at the end (in shares) at Mar. 31, 2022		31,698,424
Balance at the beginning at Dec. 31, 2022		$ 3,667	135,461,361	(118,230,463)	17,234,565
Balance at the beginning (in shares) at Dec. 31, 2022		36,668,980
Cashless exercise of stock options		$ 2	(2)
Cashless exercise of stock options (in shares)		19,530
Stock-based compensation			819,064		819,064
Issuance of common stock related to vested restricted stock units (in shares)		3,289
Issuance of common stock in At the Market offering	[3]	$ 130	3,499,462		3,499,592
Issuance of common stock in At the Market offering (in shares)	[3]	1,299,947
Net loss				(5,739,366)	(5,739,366)
Balance at the end at Mar. 31, 2023		$ 3,799	$ 139,779,885	$ (123,969,829)	$ 15,813,855
Balance at the end (in shares) at Mar. 31, 2023		37,991,746

[1] Includes gross proceeds of $14,981,299 less total issuance costs of $83,391

[2] Includes gross proceeds of $886,974, less total issuance costs of $26,609

[3] Includes gross proceeds of $3,607,827 less total issuance costs of $108,235